770 related articles for article (PubMed ID: 25362712)
1. Updated guidelines for the management of axial disease in psoriatic arthritis.
Nash P; Lubrano E; Cauli A; Taylor WJ; Olivieri I; Gladman DD
J Rheumatol; 2014 Nov; 41(11):2286-9. PubMed ID: 25362712
[TBL] [Abstract][Full Text] [Related]
2. Psoriatic arthritis and spondyloarthritis assessment and management update.
Mease P
Curr Opin Rheumatol; 2013 May; 25(3):287-96. PubMed ID: 23492739
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
Simone D; Nowik M; Gremese E; Ferraccioli GF
J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
[TBL] [Abstract][Full Text] [Related]
4. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
[TBL] [Abstract][Full Text] [Related]
5. Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.
Acosta Felquer ML; Coates LC; Soriano ER; Ranza R; Espinoza LR; Helliwell PS; FitzGerald O; McHugh N; Roussou E; Mease PJ
J Rheumatol; 2014 Nov; 41(11):2277-85. PubMed ID: 25362711
[TBL] [Abstract][Full Text] [Related]
6. 2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis.
Wendling D; Lukas C; Prati C; Claudepierre P; Gossec L; Goupille P; Hudry C; Miceli-Richard C; Molto A; Pham T; Saraux A; Dougados M
Joint Bone Spine; 2018 May; 85(3):275-284. PubMed ID: 29407043
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA.
Coates LC; Kavanaugh A; Ritchlin CT;
J Rheumatol; 2014 Nov; 41(11):2273-6. PubMed ID: 25362710
[TBL] [Abstract][Full Text] [Related]
8. Axial involvement according to ASAS criteria in an observational psoriatic arthritis cohort.
Carvalho PD; Savy F; Moragues C; Juanola X; Rodriguez-Moreno J
Acta Reumatol Port; 2017; 42(2):176-182. PubMed ID: 28693033
[TBL] [Abstract][Full Text] [Related]
9. Risk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with targeted therapies: A meta-analysis of randomized controlled trials.
Séauve M; Auréal M; Laplane S; Lega JC; Cabrera N; Coury F
Joint Bone Spine; 2024 May; 91(3):105673. PubMed ID: 38042364
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of therapies for skin symptoms of psoriasis in patients with psoriatic arthritis: a systematic review.
Boehncke WH; Alvarez Martinez D; Solomon JA; Gottlieb AB
J Rheumatol; 2014 Nov; 41(11):2301-5. PubMed ID: 25362715
[TBL] [Abstract][Full Text] [Related]
11. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.
van der Heijde D; Sieper J; Maksymowych WP; Dougados M; Burgos-Vargas R; Landewé R; Rudwaleit M; Braun J;
Ann Rheum Dis; 2011 Jun; 70(6):905-8. PubMed ID: 21540200
[TBL] [Abstract][Full Text] [Related]
12. First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register.
Lie E; Fagerli KM; Mikkelsen K; Rødevand E; Lexberg A; Kalstad S; Uhlig T; Kvien TK
Ann Rheum Dis; 2014 Oct; 73(10):1905-6. PubMed ID: 24989896
[No Abstract] [Full Text] [Related]
13. Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis.
Schoels MM; Braun J; Dougados M; Emery P; Fitzgerald O; Kavanaugh A; Kvien TK; Landewé R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Sieper J; Smolen JS; Wit Md; van der Heijde D
Ann Rheum Dis; 2014 Jan; 73(1):238-42. PubMed ID: 23740234
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs for the treatment of axial and peripheral spondyloarthritis.
Braun J; Kiltz U; Heldmann F; Baraliakos X
Expert Opin Emerg Drugs; 2015 Mar; 20(1):1-14. PubMed ID: 25575936
[TBL] [Abstract][Full Text] [Related]
15. Axial involvement in psoriatic arthritis: An update for rheumatologists.
Poddubnyy D; Jadon DR; Van den Bosch F; Mease PJ; Gladman DD
Semin Arthritis Rheum; 2021 Aug; 51(4):880-887. PubMed ID: 34198146
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria.
Ficco HM; Citera G; Cocco JA
Clin Rheumatol; 2014; 33(10):1489-93. PubMed ID: 24803232
[TBL] [Abstract][Full Text] [Related]
17. Biological therapies in the spondyloarthritides--the current state.
Braun J; Sieper J
Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis.
Orbai AM; Weitz J; Siegel EL; Siebert S; Savage LJ; Aydin SZ; Luime JJ; Elkayam O; Neerinckx B; Urbancek S; de Vlam K; Ritchlin CT;
J Rheumatol; 2014 Nov; 41(11):2290-4. PubMed ID: 25362713
[TBL] [Abstract][Full Text] [Related]
19. [Spondyloarthritis including psoriatic arthritis].
Rudwaleit M; Märker-Hermann E
Dtsch Med Wochenschr; 2011 Oct; 136(40):2033-6. PubMed ID: 21960334
[No Abstract] [Full Text] [Related]
20. ASAS classification criteria for axial spondyloarthritis: time to modify.
Akkoc N; Khan MA
Clin Rheumatol; 2016 Jun; 35(6):1415-23. PubMed ID: 27094940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
